Millions of Britons use GLP-1 weight loss drugs to change how they drink, eat and choose places. For the beverage business, the shift may be to examine the revenue models generated by alcohol. For anyone inclined to view GLP 1 drugs in hospitality as someone else’s concern, the numbers already suggest otherwise. According to KAM, … Read more
In a bid to compete with cheaper generics, Danish drugmaker Novo Nordisk on Monday announced a 36 percent and 48 percent price cut for its injectable semaglutide brands Ozympic and Vigovi in India, respectively. However, senior executives told Business Standard that the company is not planning a similar move for its oral semaglutide brand, Rebelsos. … Read more
According to a recent trial, a new type of daily pill has proven to be more effective than its currently available counterparts for weight loss and blood sugar control. The drug, known as orforgliperone, could be a game changer in the rapidly expanding oral weight loss drug market. The arrival of the injectable weight loss … Read more